part 5 adrenoceptor antagonists 1. receptor antagonists 2. receptor antagonists 3. , receptor...
TRANSCRIPT
Part 5Part 5
Adrenoceptor AntagonistsAdrenoceptor Antagonists
1. 1. receptor antagonists receptor antagonists
2. 2. receptor antagonists receptor antagonists
3. 3. , , receptor antagonists receptor antagonists
Epinephrine reversalEpinephrine reversal ((肾上腺素作用的翻转肾上腺素作用的翻转))
1. 1. receptor antagonists receptor antagonists
1-1 1-1 11, , 2 2 receptor antagonistsreceptor antagonists
Short-actingShort-acting
Phentolamine Phentolamine 酚妥拉明酚妥拉明
N
NCH3
HO
N CH2
H
1.1 1.1 PharmacologyPharmacology
(1) Vasodilatation(1) Vasodilatation Blocking Blocking 1 1 receptor; direct actionreceptor; direct action
(2) Stimulating heart(2) Stimulating heart ReflexReflex ;; blocking blocking 2 2 receptor receptor ~~ NE release NE release
(3) Cholinergic and histamine-like effects(3) Cholinergic and histamine-like effects Contraction of GI smooth muscles,Contraction of GI smooth muscles, Gastric acid secretion Gastric acid secretion
1. 1. receptor antagonists receptor antagonists
1.2 1.2 Clinical usesClinical uses
(1) Peripheral vascular diseases(1) Peripheral vascular diseases Acrocyanosis, Raynaud’s diseaseAcrocyanosis, Raynaud’s disease
(2) Local vasoconstrictor extravasation(2) Local vasoconstrictor extravasation
1. 1. receptor antagonists receptor antagonists
(3) Shock(3) Shock cardiac output cardiac output ; ; redistribution of blood flow; redistribution of blood flow; shift of fluid from interstitial compartment shift of fluid from interstitial compartment
to vascular compartment; to vascular compartment; pulmonary pressure pulmonary pressure ;; should be used after fully adequate should be used after fully adequate
replacement of intravascular fluidreplacement of intravascular fluid
1. 1. receptor antagonists receptor antagonists
(4) Acute myocardial infarction and conges(4) Acute myocardial infarction and congestive heart failuretive heart failure
after-load after-load ; ; cardiac output cardiac output
1. 1. receptor antagonists receptor antagonists
(5) Pheochromocytoma(5) Pheochromocytoma pre- and post-operation usespre- and post-operation uses diagnosisdiagnosis
(6) Others:(6) Others: impotency ( impotency ( 阳痿阳痿 ))
1. 1. receptor antagonists receptor antagonists
1.3 1.3 Adverse effectsAdverse effects
(1) Postural hypotension(1) Postural hypotension
(2) Reflex heart stimulation(2) Reflex heart stimulation tachycardia, arrhythmia, angina pectoristachycardia, arrhythmia, angina pectoris
(3) G.I. reactions(3) G.I. reactions
(4) Other(4) Other central depressioncentral depression
1. 1. receptor antagonists receptor antagonists
TolazolineTolazoline 妥拉唑啉妥拉唑啉
weak effectsweak effects more severe adverse effectsmore severe adverse effects
1. 1. receptor antagonists receptor antagonists
Long-actingLong-acting
Longer action durationLonger action durationused for peripheral vasculardiseasesperipheral vasculardiseases anti-shockanti-shock pheochromocytomapheochromocytoma improving urinary flow in patients with bimproving urinary flow in patients with b
enign prostatic hypertrophyenign prostatic hypertrophy
Phenoxybenzamine Phenoxybenzamine 酚苄明酚苄明
1. 1. receptor antagonists receptor antagonists
1-2 1-2 1 1 receptor antagonistsreceptor antagonists
prazosinprazosin ((哌唑嗪哌唑嗪)) , for hypertension , for hypertension treatmenttreatment
tamsulosintamsulosin ((坦洛新坦洛新)) , for benign pros, for benign prostatic hypertrophytatic hypertrophy
1-3 1-3 22 receptor antagonists receptor antagonists
yohimbineyohimbine ((育亨宾育亨宾))
1. 1. receptor antagonists receptor antagonists
2.1 2.1 ADMEADME
First-pass elimination,First-pass elimination, lower bioavailability: propranolollower bioavailability: propranolol
Hepatic metabolism and renal excretion, Hepatic metabolism and renal excretion, hepatic and renal functions alter the effects of hepatic and renal functions alter the effects of the drugs and result in large individual the drugs and result in large individual variationvariation
Thus, Thus, dose individualizationdose individualization is necessary. is necessary.
2. 2. receptor antagonists receptor antagonists
2.2 2.2 Pharmacological effectsPharmacological effects
(1) (1) receptor blockade receptor blockade
A. Cardiovascular effectsA. Cardiovascular effects :: Depressing heart: Depressing heart: reduction in HR, A-V conduction,reduction in HR, A-V conduction,
automaticity, cardiac output, oxygen consumption automaticity, cardiac output, oxygen consumption Hypotension:Hypotension: hypotensive effects only in hypotensive effects only in hypertensihypertensi
ve patientsve patients; ; peripheral blood flow peripheral blood flow , BP , BP in in normal subjectsnormal subjects..
2. 2. receptor antagonists receptor antagonists
Blockade of Blockade of –adrenoceptor cardial responses –adrenoceptor cardial responses by propranololby propranolol
B. Bronchial smooth musclesB. Bronchial smooth muscles inducing bronchial smooth muscle contraction in inducing bronchial smooth muscle contraction in
asthmatic patientsasthmatic patients
C. MetabolismC. Metabolism lipolysis lipolysis , glycogenolysis , glycogenolysis , potentiating insulin e, potentiating insulin e
ffects ~ hypoglycemiaffects ~ hypoglycemia
D. Renin secretionD. Renin secretion decreasing secretion of renindecreasing secretion of renin
2. 2. receptor antagonists receptor antagonists
(2) Intrinsic sympathomimetic effects(2) Intrinsic sympathomimetic effects Some drugs: HR Some drugs: HR , output , output
(3) Membrane-stabilizing effects(3) Membrane-stabilizing effectsLarger doses of some drugs: quinidine-like effeLarger doses of some drugs: quinidine-like effe
cts due to Nacts due to Na++ channel block channel block
(4) Others(4) OthersLowering intraocular pressure;Lowering intraocular pressure; Inhibiting platelet aggregationInhibiting platelet aggregation
2. 2. receptor antagonists receptor antagonists
2.3 2.3 Clinical usesClinical uses
(1) Arrhythmia(1) Arrhythmia :: supraventricular, sympathetisupraventricular, sympathetic activity c activity
(2) Hypertension(2) Hypertension
(3) Angina pectoris and myocardial infarction(3) Angina pectoris and myocardial infarction
(4) Chronic heart failure(4) Chronic heart failure
(5) Others: (5) Others: hyperthyroidism, migraine headachhyperthyroidism, migraine headache, glaucomae, glaucoma (( timololtimolol )) , , etcetc..
2. 2. receptor antagonists receptor antagonists
Effect of a Effect of a receptor antagonist on the mortality of ch receptor antagonist on the mortality of chronic heart failureronic heart failure
2.4 2.4 Adverse effectsAdverse effects
(1) Worsening of asthma: (1) Worsening of asthma: contraindicated in bronccontraindicated in bronchial asthmatic patientshial asthmatic patients
(2) Heart depression: (2) Heart depression: contraindicated in heart failcontraindicated in heart failure, severe A-V block, sinus bradycardiaure, severe A-V block, sinus bradycardia
(3) Worsening of peripheral vascular constriction(3) Worsening of peripheral vascular constriction (4) Withdrawal syndrome(4) Withdrawal syndrome :: up-regulation of up-regulation of re re
ceptorsceptors (5) Others(5) Others :: central depression, hypoglycemia, central depression, hypoglycemia, etcetc..
2. 2. receptor antagonists receptor antagonists
2. 2. receptor antagonists receptor antagonists
2.5 2.5 Representative drugsRepresentative drugs
Propranolol Propranolol 普萘洛尔普萘洛尔
O CH2CHCH2NHCH
OHCH3
CH3
11, , 2 2 receptor blocking receptor blocking
no intrinsic activityno intrinsic activity first-elimination after oral administration, first-elimination after oral administration,
individual variation of bioavailabilityindividual variation of bioavailability
Propranolol Propranolol 普萘洛尔普萘洛尔
2. 2. receptor antagonists receptor antagonists
For treatment of glaucoma (wide-angle)For treatment of glaucoma (wide-angle)
Timolol Timolol 噻马洛尔噻马洛尔
2. 2. receptor antagonists receptor antagonists
1 1 receptor antagonists, no intrinsic activityreceptor antagonists, no intrinsic activity
atenolol :atenolol : longer t longer t1/21/2, once daily, once daily
usually used for treatment of hypertensionusually used for treatment of hypertension
Atenolol Atenolol 阿替洛尔阿替洛尔
Metoprolol Metoprolol 美托洛尔美托洛尔
2. 2. receptor antagonists receptor antagonists
3. α, 3. α, receptor antagonists receptor antagonists
blockingblocking α, β receptors, β> αα, β receptors, β> α usually used for treatment of hyperusually used for treatment of hyper
tensiontension
Labetolol Labetolol 拉贝洛尔拉贝洛尔
3. α, 3. α, receptor antagonists receptor antagonists
α, β receptor blocking, β> αα, β receptor blocking, β> α
SS(-) isomer: βand α receptor blocking(-) isomer: βand α receptor blocking RR(+) isomer: α receptor blocking(+) isomer: α receptor blocking
usually used for treatment of hypertensiousually used for treatment of hypertension and n and chronic heart failurechronic heart failure
Carvedilol Carvedilol 卡维地洛卡维地洛
Part 6Part 6
Local AnestheticsLocal Anesthetics
COCH2CH2N
OC2H5
H2N
C2H5
NHCCH2N
OC2H5
C2H5
CH3
CH3
COCH2CH2N
OCH3
CH3
HN
H9C4
procaineprocaine
普鲁卡因普鲁卡因
lidocainelidocaine
利多卡因利多卡因
tetracainetetracaine
丁 卡 因丁 卡 因
Local anestheticsLocal anesthetics
1. 1. Pharmacological effectsPharmacological effects
(1) Local anesthetic effects(1) Local anesthetic effects
inhibiting Nainhibiting Na++ inward flow and the conduction of nerve inward flow and the conduction of nerve fibersfibers
sensory (fine – thick) sensory (fine – thick) CNS CNS (inhibiting - excitatory) (inhibiting - excitatory) ANS ANS motor nerves motor nerves muscles muscles
The The mechanism of mechanism of local local anestheticsanesthetics
Blocking NaBlocking Na+ +
channels on channels on the nerve the nerve fibersfibers
The mechanism of The mechanism of local anestheticslocal anesthetics
Intracellular blockade Intracellular blockade of Naof Na+ + channelchannel
Local anestheticsLocal anesthetics
(2) Systemic effects(2) Systemic effects (( Adverse effectsAdverse effects ))
Depressing CNSDepressing CNS :: excitation - depressionexcitation - depression
Cardiovascular effectsCardiovascular effects :: heart depression; vaheart depression; vasodilatation; lowering BPsodilatation; lowering BP
combined with epinephrine:combined with epinephrine: reducing absorption areducing absorption and systemic effectsnd systemic effects
( but contraindicated in: ( but contraindicated in: terminal tissues; epinephrine contraiterminal tissues; epinephrine contraindications )ndications )
2. 2. Clinical usesClinical uses
(1) Surface anesthesia ((1) Surface anesthesia ( 表面麻醉表面麻醉)) penetrationpenetration
(2) Infiltration anesthesia (2) Infiltration anesthesia ((浸润麻醉浸润麻醉))
(3) Conduction anesthesia (3) Conduction anesthesia ((传导麻醉传导麻醉))
Local anestheticsLocal anesthetics
(4) Epidural anesthesia ((4) Epidural anesthesia ( 硬脊膜外麻醉硬脊膜外麻醉 )) Avoiding misdirection into cerebrospinal fluidAvoiding misdirection into cerebrospinal fluid
(5) Subarachnoid anesthesia ((5) Subarachnoid anesthesia ( 蛛网膜下腔麻蛛网膜下腔麻
醉 醉 , , 腰麻腰麻)) head-up position;head-up position; hyperbaric solution;hyperbaric solution; hypotension: hypotension: prevention with ephedrineprevention with ephedrine
Local anestheticsLocal anesthetics
3. 3. Adverse effectsAdverse effects
(1) Systemic effects(1) Systemic effects depression of CNS:depression of CNS: excitation – depression – respi excitation – depression – respi
ratory depressionratory depression cardiovascular effects:cardiovascular effects: hypotension; arrhythmia hypotension; arrhythmia
(2) Allergic reactions(2) Allergic reactions urticaria, bronchoconstriction; anaphylactic shockurticaria, bronchoconstriction; anaphylactic shock
Local anestheticsLocal anesthetics
4. 4. Special agentsSpecial agents
Efffect Toxicity Pene-Efffect Toxicity Pene- UsesUses trationtration
procaineprocaine weak weak weak can not be used weak weak weak can not be used 普鲁卡因普鲁卡因 (allergic) for sur(allergic) for surfaceface skin allergic testskin allergic test
lidocainelidocaine stronger lower strongerstronger lower stronger for various uses for various uses ;;利多卡因利多卡因 anti-arrhythmiaanti-arrhythmia
tetracainetetracaine stronger stronger strongerstronger stronger stronger mainly for surface mainly for surface丁卡因丁卡因
Local anestheticsLocal anesthetics